See the Billboy HC thread LANI. Biota have been very quiet about LANI, so whilst I don't assign a high confidence level to seeking alpha content, my expectations are that the Cochrane report killed any further commercial interest in neuraminidase inhibiters (at least in the US and Europe).
BTA Price at posting:
57.0¢ Sentiment: None Disclosure: Held